HCA vs RAPT · P/E 17, rev $75.60B vs $132.1M cap
HCA Holdings Inc (HCA) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the HCA and RAPT stock pages for the full models.
Not investment advice.